Medial nigral dopamine neurons have rich neurotrophin support in humans.
To assess the action of neurotrophin in human dopaminergic neurons, we studied the immunolocalization of neurotrophins or trks in human substantia nigra pars compacta (SNc). The neuromelanin-containing neurons in the SNc showed immunoreactivities for neurotrophins or trks, suggesting an autocrine/paracrine regulation. Quantitative analysis revealed that the percentage of those expressing NGF-like immunoreactivity (NGF-LI), BDNF-LI, NT3-LI, trkA-LI, trkB-LI, or trkC-LI was 66%, 74%, 85%, 66%, 71% or 86%, respectively. The percentage of cells expressing neurotrophins or trks was higher in the medial part than in the lateral part of the SNc. The preferential expression of neurotrophin-trk systems in the medial neurons may, at least partially, explain the differential susceptibility in Parkinson's disease.
Department of Neurology, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
T
T
Nishio
S
S
Furukawa
I
I
Akiguchi
N
N
Sunohara
D000368:Aged; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008543:Melanins / Q000378:metabolism; D008875:Middle Aged; D009414:Nerve Growth Factors / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism / Q000502:physiology*; D020933:Neurotrophin 3; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism; D013378:Substantia Nigra / Q000166:cytology* / Q000378:metabolism
D019208:Brain-Derived Neurotrophic Factor; D008543:Melanins; D009414:Nerve Growth Factors; D020933:Neurotrophin 3; D020794:Receptor Protein-Tyrosine Kinases